Acute respiratory distress syndrome and profound hypoxemia are the main causes of death in coronavirus disease-2019 pneumonia.
1 Ruan Q. Yang K. Wang W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan.
China. Intensive Care Med. 2020; 46 : 846-848 Crossref PubMed Scopus (851) Google Scholar
Despite the wide use of mechanical ventilation with low-volume, low-pressure, and prone position ventilation strategies, the mortality is still as high as 60% in severe cases.
2 Yang X. Yu Y. Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study.
Lancet Respir Med. 2020; 8 : 475-481 Abstract Full Text Full Text PDF PubMed Scopus (1783) Google Scholar
In such situations, ECMO might be a life-saving measure, but it also is associated with hemorrhagic complications.
3 Henry B.M. COVID-19, ECMO, and lymphopenia: A word of caution.
Lancet Respir Med. 2020; 8 : e24 Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar
,4 Augoustides J.G. Extracorporeal membrane oxygenation – crucial considerations during the coronavirus crisis.
J Cardiothorac Vasc Anesth. 2020; 34 : 1720-1722 Abstract Full Text Full Text PDF PubMed Scopus (9) Google Scholar
In addition, because of a relatively complex management, various complications may occur during ECMO support.
5 Keller S.P. Contemporary approaches in the use of extracorporeal membrane oxygenation to support patients waiting for lung transplantation.
Ann Cardiothorac Surg. 2020; 9 : 29-41 Crossref PubMed Google Scholar
,6 Hoyler M.M. Flynn B. Iannacone E.M. et al. Clinical management of venoarterial extracorporeal membrane oxygenation.
J Cardiothorac Vasc Anesth. 2020; 34 : 2776-2792 Abstract Full Text Full Text PDF Scopus (4) Google Scholar